Phillips v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided July 29, 2019·No. 16-906·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 16-906V

************************* * * JOHN PHILLIPS, * * * Petitioner, * Special Master Katherine E. Oler * v. * * * Filed: May 16, 2019 SECRETARY OF HEALTH AND * HUMAN SERVICES, * Interim Attorneys’ Fees and Costs; * * Expert Costs Respondent. * * ************************* *

Michael A. Firestone, Marvin Firestone, MD, JD & Associates LLP, San Mateo, CA, for Petitioner.

Voris E. Johnson, U.S. Department of Justice, Washington, DC, for Respondent.

DECISION AWARDING INTERIM EXPERT WITNESS COSTS1

On July 29, 2016, John Robert Phillips (“Petitioner”) filed a petition2 for compensation under the National Vaccine Injury Compensation Program,3 alleging that he developed chronic idiopathic thrombocytopenic purpura (“ITP”) as a result of the intranasal influenza (“flu”) and/or intramuscular injection of the Human Papillomavirus (“HPV”) vaccinations administered on November 20, 2013. See Pet., ECF No. 1.

1 Because this unpublished decision contains a reasoned explanation for the action in this case, I intend to post this decision on the United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2012)). This means the ruling will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the Decision in its present form will be available. Id. 2 This matter was initially assigned to former Special Master George Hastings and then re-assigned to Special Master Brian Corcoran on October 10, 2017, before being assigned to my docket on December 5, 2017. 3 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). Along with his medical records, Petitioner filed an expert report authored by Dr. S. Sohail Ahmed on August 4, 2016. Ex. 10, ECF No. 6. Respondent filed his Rule 4(c) Report on November 25, 2016 recommending that compensation be denied. ECF No. 12. With his Report, Respondent included two expert reports by Dr. Neil Romberg and Dr. Joan Gill. Exs. A, C; ECF No. 13. Petitioner then filed two responsive letters by Dr. Ahmed on January 12, 2017 and January 30, 2017. Ex. 27, ECF No. 19; Ex. 38, ECF No. 22. On October 16, 2017, Petitioner filed an additional expert report authored by Dr. Yehuda Shoenfeld. Ex. 40, ECF No. 31. Respondent then filed an expert report by Dr. John Strouse, Ex. E, ECF No. 44, on October 9, 2018 and a supplemental expert report by Dr. Neil Romberg on November 7, 2018. Ex. G, ECF No. 46. In response, Petitioner filed a supplemental rebuttal letter by Dr. Ahmed on December 13, 2018. Ex. 69, ECF No. 50.

I. The Instant Motion

On December 6, 2018, Petitioner filed an application for interim attorneys’ costs, specifically expert witness costs, requesting a total of $43,880.00: $30,380.00 for Dr. Ahmed, $8,500 for Dr. Shoenfeld, and $5,000.00 for Petitioner who paid $3,000 to Dr. Ahmed and $2,000 to Dr. Shoenfeld in retainer fees. See Pet’r’s Mot., ECF No. 47. Petitioner is not seeking interim attorneys’ fees at this time. Id.

Respondent filed a response to Petitioner’s application on December 7, 2018. Resp’t’s Resp., ECF No. 48. Respondent argues that “[n]either the Vaccine Act nor Vaccine Rule 13 requires [R]espondent to file a response to a request by a petitioner for an award of attorneys’ fees and costs.” Id. at 1. Respondent adds that he “defers to [me] to determine whether or not petitioner has met the legal standard for an award of interim fees and costs” in this case. Id. at 2. Additionally, he “respectfully requests that [I] exercise [my] discretion and determine a reasonable award for [P]etitioner’s expert witness costs, if any at this time.” Id. at 3. Respondent has not raised any issue with respect to reasonable basis. See Resp’t’s Resp.

For the reasons discussed below, I hereby GRANT IN PART Petitioner’s application, awarding a total of $36,380.00 in costs.

II. Legal Standard for Interim Attorneys’ Fees and Costs The Federal Circuit has held that an award of interim attorneys’ fees and costs is permissible under the Vaccine Act. Shaw v. Sec’y of Health & Human Servs., 609 F.3d 1372 (Fed. Cir. 2010); Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343 (Fed. Cir. 2008). The Federal Circuit has held that “Congress made clear that denying interim attorneys' fees under the Vaccine Act is contrary to an underlying purpose of the Vaccine Act.” Cloer v. Sec’y of Health & Human Servs., 675 F.3d 1358, 1361-62 (Fed. Cir. 2012).

In Avera, the Federal Circuit stated, “[i]nterim fees are particularly appropriate in cases where proceedings are protracted, and costly experts must be retained.” 515 F.3d at 1352. Likewise, in Shaw, the Federal Circuit held that “where the claimant establishes that the cost of litigation has imposed an undue hardship and there exists a good faith basis for the claim, it is proper for the special master to award interim attorneys' fees.” 609 F.3d at 1375. However, Avera did not exclusively define when interim fees are appropriate; rather, it has been interpreted to allow special masters discretion. See Kirk v. Sec’y of Health & Human Servs., No. 08-241V, 2013 WL 775396, at *2 (Fed. Cl. Spec. Mstr. Mar. 13, 2009); Bear v. Sec’y of Health & Human Servs., No. 11-362V, 2013 WL 691963, at *4 (Fed. Cl. Spec. Mstr. Feb. 4, 2013). Even though it has been argued that a petitioner must meet the three Avera criteria -- protracted proceedings, costly expert testimony, and undue hardship -- special masters have instead treated these criteria as possible factors in a flexible balancing test. Avera, 515 F.3d at 1352; Al-Uffi v. Sec’y of Health & Human Servs., No. 13-956V, 2015 WL 6181669, at *7 (Fed. Cl. Spec. Mstr. Sept. 30, 2015).

The undue hardship inquiry looks at more than just financial involvement of a petitioner; it also looks at any money expended by a petitioner’s counsel. Kirk, 2013 WL 775396, at *2 (finding “the general principle underlying an award of interim fees was clear: avoid working a substantial financial hardship on petitioners and their counsel.”).

By the time an entitlement hearing may be scheduled in this case, Petitioner, and her counsel, will have been litigating this claim for more than three years. Thus, I find it reasonable to award interim costs at this juncture to avoid undue hardship for Petitioner and his expert witnesses.

III.

Free access — add to your briefcase to read the full text and ask questions with AI

Phillips v. Secretary of Health and Human Services, (uscfc 2019).

Phillips v. Secretary of Health and Human Services (Phillips v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related